January 4, 2018 / 12:24 PM / 5 months ago

BRIEF-Chemocentryx Secures Up To $100 Million In New Capital Commitments

Jan 4 (Reuters) - Chemocentryx Inc:

* CHEMOCENTRYX SECURES UP TO $100 MILLION IN NEW CAPITAL COMMITMENTS

* CHEMOCENTRYX INC SAYS WILL RECEIVE $50 MILLION MILESTONE PAYMENT FROM VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

* CHEMOCENTRYX INC - CO ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL

* CHEMOCENTRYX INC SAYS ALSO ENTERS INTO $50 MILLION GROWTH CAPITAL FINANCING AGREEMENT WITH HERCULES CAPITAL

* CHEMOCENTRYX - ‍ADDITIONAL CAPITAL TO PROVIDE FUNDING TO ADVANCE AVACOPAN THROUGH TOPLINE DATA FROM PHASE III ADVOCATE TRIAL

* CHEMOCENTRYX INC - ADDITIONAL CAPITAL ALSO EXPECTED TO PROVIDE FUNDING​ FOR‍ POTENTIAL REGISTRATION FILINGS IN U.S. AND EU. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below